Send us a text

• Petition · Urgent Call for U.S. Children to Have Access to an FDA-Approved Low-Dose Atropine - United States · Change.org

About Patrick Johnson, Ph.D.

Patrick Johnson joined Sydnexis as Chief Business Officer in 2017. He was instrumental in the Series A and B financings at Sydnexis as well as the corporate alliance with Santen Pharmaceuticals that was established in 2021.

Prior to his role at Sydnexis, Patrick was the Vice President of Corporate and Business Development at Allergan, a publicly traded, large-cap pharmaceutical company. At Allergan, Patrick was responsible for establishing dozens of corporate partnerships as well as mergers and acquisitions in eyecare (Allergan’s largest therapeutic area) and drug delivery. Prior to Allergan, Patrick was a co-founder of Chimeros, a biotechnology start-up company founded in Santa Barbara in 2005, where he was Vice President of Business Development in addition to leading scientific teams as Director of Biology. Before co-founding Chimeros, Patrick was an adjunct faculty member at the University of California, Santa Barbara (USCB) where he was simultaneously conducting research in the Center for the Study of Macular Degeneration while teaching classes in Neurobiology, Developmental Biology, Introductory Biology, and Biotechnology and Society.

Patrick holds a B.S. in biopsychology and a Ph.D. in molecular, cellular, and developmental biology, both from USCB. His doctoral research focused on the development of visual pathways in mammals and his post-doctoral research focused on diseases of the eye, spanning both acute injury (retinal detachment) and chronic disease (age-related macular degeneration).

Send us a text

• Petition · Urgent Call for U.S. Children to Have Access to an FDA-Approved Low-Dose Atropine - United States · Change.org

About Dr. Glazier

Dr. Glazier is the founder and visionary behind FluoreSCENE Group, the eye care industry's most highly engaged media org. He is founder of Shady Grove Eye and Vision Care, a large medical model practice in Rockville, MD. Honors and accomplishments include selection as one of the 50 most influential optometrists by his peers, 250 “innovators in Optometry by PCON magazine, Maryland Optometrist of the year in 2017.

Dr Glazier was the commencement speaker for the New England College of Optometry in 2019 and awarded a Presidential medal by the institution. In 2020 he was appointed to the Board of Trustees of the institution. In 2021 and 2022 he was named in the top 3 of “America’s Best Eye Doctors” by Newsweek Magazine. In 2023 he was presented the Distinguished Service Award by the American Optometric Association. He has presented over 100 invited lectures, written numerous journal articles, authored 2 books, has 11 issued and 4 pending patents in ophthalmology and computer science and authored 1 peer reviewed publication in the journal Clinical Ophthalmology. Dr Glazier consults with numerous companies inside and outside the industry, sits on several advisory boards and has been interviewed on CNN, NBC, CBS, Entrepreneur and INC magazines. He resides in Rockville Maryland

Send us a text